Jennifer L. Leddon

911 total citations
15 papers, 700 citations indexed

About

Jennifer L. Leddon is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Jennifer L. Leddon has authored 15 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Genetics and 6 papers in Immunology. Recurrent topics in Jennifer L. Leddon's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Jennifer L. Leddon is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Jennifer L. Leddon collaborates with scholars based in United States and Netherlands. Jennifer L. Leddon's co-authors include Yipin Wu, Jeffrey Buis, Mark Eckersdorff, Gerwin Westfield, Yibin Deng, Sandy Chang, JoAnn Sekiguchi, David O. Ferguson, Timothy P. Cripe and Chun‐Yu Chen and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Jennifer L. Leddon

13 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer L. Leddon United States 9 404 251 167 114 83 15 700
Fernanda I. Staquicini United States 14 465 1.2× 177 0.7× 64 0.4× 132 1.2× 90 1.1× 21 795
Aparajita Khatri Australia 14 398 1.0× 137 0.5× 209 1.3× 77 0.7× 67 0.8× 23 704
Surya Murty United States 13 231 0.6× 229 0.9× 112 0.7× 371 3.3× 127 1.5× 25 825
Zihua Zeng United States 19 975 2.4× 160 0.6× 121 0.7× 305 2.7× 119 1.4× 39 1.2k
Yong Serk Park South Korea 16 555 1.4× 90 0.4× 113 0.7× 202 1.8× 68 0.8× 38 903
Jilian R. Melamed United States 14 638 1.6× 60 0.2× 82 0.5× 175 1.5× 121 1.5× 22 884
Dominique Desplancq France 15 806 2.0× 127 0.5× 122 0.7× 58 0.5× 121 1.5× 26 1.0k
Alexandra S. Piotrowski-Daspit United States 15 633 1.6× 107 0.4× 112 0.7× 198 1.7× 107 1.3× 28 1.0k
Huizi Sha China 17 577 1.4× 401 1.6× 123 0.7× 309 2.7× 277 3.3× 41 1.1k
Minxue Zheng China 17 734 1.8× 212 0.8× 70 0.4× 67 0.6× 19 0.2× 37 1.0k

Countries citing papers authored by Jennifer L. Leddon

Since Specialization
Citations

This map shows the geographic impact of Jennifer L. Leddon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer L. Leddon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer L. Leddon more than expected).

Fields of papers citing papers by Jennifer L. Leddon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer L. Leddon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer L. Leddon. The network helps show where Jennifer L. Leddon may publish in the future.

Co-authorship network of co-authors of Jennifer L. Leddon

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer L. Leddon. A scholar is included among the top collaborators of Jennifer L. Leddon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer L. Leddon. Jennifer L. Leddon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Daneng, Anthony F. Shields, Hirva Mamdani, et al.. (2024). Oncolytic virus CF33-hNIS monotherapy for the treatment of gastrointestinal (GI) malignancies.. Journal of Clinical Oncology. 42(3_suppl). 749–749. 1 indexed citations
2.
Shaikh, Hira, Pavel Brodskiy, Joanne Xiu, et al.. (2022). Genomic profiling and outcomes of BRAF V600E mutated papillary thyroid cancer.. Journal of Clinical Oncology. 40(16_suppl). e18086–e18086.
3.
Leddon, Jennifer L., et al.. (2021). Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors. The Laryngoscope. 131(7). E2413–E2419. 3 indexed citations
4.
Leddon, Jennifer L., Sulsal Haque, Shuchi Gulati, et al.. (2021). Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.. Journal of Clinical Oncology. 39(15_suppl). 6031–6031. 2 indexed citations
5.
Denton, Nicholas, Chun‐Yu Chen, Brian Hutzen, et al.. (2018). Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment. Molecular Therapy — Oncolytics. 11. 62–74. 44 indexed citations
6.
Denton, Nicholas, Chun‐Yu Chen, Brian Hutzen, et al.. (2016). 518. Tumor Associated Macrophages Mitigate Oncolytic Herpes Simplex Virus Efficacy in Part Through TGF-β Signaling. Molecular Therapy. 24. S206–S207.
7.
Friedman, Gregory K., Elizabeth A. Beierle, G. Yancey Gillespie, et al.. (2015). Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children. Molecular Therapy — Oncolytics. 2. 15016–15016. 12 indexed citations
8.
Cripe, Timothy P., Chun‐Yu Chen, Nicholas Denton, et al.. (2015). Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children. Molecular Therapy — Oncolytics. 2. 15015–15015. 20 indexed citations
9.
Haworth, Kellie B., Michael Arnold, Christopher R. Pierson, et al.. (2015). Characterization of MHC Class I and β‐2‐Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune‐Based Therapeutic Trials. Pediatric Blood & Cancer. 63(4). 618–626. 10 indexed citations
10.
Leddon, Jennifer L., Chun‐Yu Chen, Mark A. Currier, et al.. (2014). Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity. Molecular Therapy — Oncolytics. 1. 14010–14010. 31 indexed citations
11.
Haworth, Kellie B., Jennifer L. Leddon, Chun‐Yu Chen, et al.. (2014). Going back to class I: MHC and immunotherapies for childhood cancer. Pediatric Blood & Cancer. 62(4). 571–576. 57 indexed citations
12.
Currier, Mark A., Allyson Sholl, Kelly Crawford, et al.. (2013). VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells. Molecular Therapy. 21(5). 1014–1023. 34 indexed citations
13.
Browne, Andrew, Jennifer L. Leddon, Mark A. Currier, et al.. (2011). Cancer Screening by Systemic Administration of a Gene Delivery Vector Encoding Tumor-Selective Secretable Biomarker Expression. PLoS ONE. 6(5). e19530–e19530. 6 indexed citations
14.
Buis, Jeffrey, Yipin Wu, Yibin Deng, et al.. (2008). Mre11 Nuclease Activity Has Essential Roles in DNA Repair and Genomic Stability Distinct from ATM Activation. Cell. 135(1). 85–96. 269 indexed citations
15.
Everts, Maaike, Vaibhav Saini, Jennifer L. Leddon, et al.. (2006). Covalently Linked Au Nanoparticles to a Viral Vector:  Potential for Combined Photothermal and Gene Cancer Therapy. Nano Letters. 6(4). 587–591. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernanda I. Staquicini Breakdown of academic impact, for papers by Aparajita Khatri Breakdown of academic impact, for papers by Surya Murty Breakdown of academic impact, for papers by Zihua Zeng Breakdown of academic impact, for papers by Yong Serk Park Breakdown of academic impact, for papers by Jilian R. Melamed Breakdown of academic impact, for papers by Dominique Desplancq Breakdown of academic impact, for papers by Alexandra S. Piotrowski-Daspit Breakdown of academic impact, for papers by Huizi Sha Breakdown of academic impact, for papers by Minxue Zheng
Rankless by CCL
2026